chr16-21111703-A-G
Position:
Variant summary
Our verdict is Benign. Variant got -17 ACMG points: 0P and 17B. BP4_StrongBP6_Very_StrongBP7BS2
The NM_001347886.2(DNAH3):āc.1842T>Cā(p.Asp614=) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000661 in 1,613,950 control chromosomes in the GnomAD database, including 7 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (ā ā ).
Frequency
Genomes: š 0.00064 ( 0 hom., cov: 32)
Exomes š: 0.00066 ( 7 hom. )
Consequence
DNAH3
NM_001347886.2 synonymous
NM_001347886.2 synonymous
Scores
2
Clinical Significance
Conservation
PhyloP100: -1.15
Genes affected
DNAH3 (HGNC:2949): (dynein axonemal heavy chain 3) This gene belongs to the dynein family, whose members encode large proteins that are constituents of the microtubule-associated motor protein complex. This complex is composed of dynein heavy, intermediate and light chains, which can be axonemal or cytoplasmic. This protein is an axonemal dynein heavy chain. It is involved in producing force for ciliary beating by using energy from ATP hydrolysis. Alternative splicing results in multiple transcript variants encoding distinct isoforms. [provided by RefSeq, Dec 2016]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -17 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.62).
BP6
Variant 16-21111703-A-G is Benign according to our data. Variant chr16-21111703-A-G is described in ClinVar as [Likely_benign]. Clinvar id is 402727.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=-1.15 with no splicing effect.
BS2
High AC in GnomAd4 at 97 AD gene.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
DNAH3 | NM_001347886.2 | c.1842T>C | p.Asp614= | synonymous_variant | 14/62 | ENST00000698260.1 | NP_001334815.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
DNAH3 | ENST00000698260.1 | c.1842T>C | p.Asp614= | synonymous_variant | 14/62 | NM_001347886.2 | ENSP00000513632 | P1 | ||
DNAH3 | ENST00000261383.3 | c.2022T>C | p.Asp674= | synonymous_variant | 14/62 | 1 | ENSP00000261383 | |||
DNAH3 | ENST00000685858.1 | c.2022T>C | p.Asp674= | synonymous_variant | 14/62 | ENSP00000508756 | ||||
DNAH3 | ENST00000396036.5 | n.2118T>C | non_coding_transcript_exon_variant | 14/16 | 2 |
Frequencies
GnomAD3 genomes AF: 0.000637 AC: 97AN: 152162Hom.: 0 Cov.: 32
GnomAD3 genomes
AF:
AC:
97
AN:
152162
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.00126 AC: 317AN: 251268Hom.: 4 AF XY: 0.00116 AC XY: 158AN XY: 135810
GnomAD3 exomes
AF:
AC:
317
AN:
251268
Hom.:
AF XY:
AC XY:
158
AN XY:
135810
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.000664 AC: 970AN: 1461788Hom.: 7 Cov.: 31 AF XY: 0.000679 AC XY: 494AN XY: 727194
GnomAD4 exome
AF:
AC:
970
AN:
1461788
Hom.:
Cov.:
31
AF XY:
AC XY:
494
AN XY:
727194
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.000637 AC: 97AN: 152162Hom.: 0 Cov.: 32 AF XY: 0.000673 AC XY: 50AN XY: 74322
GnomAD4 genome
AF:
AC:
97
AN:
152162
Hom.:
Cov.:
32
AF XY:
AC XY:
50
AN XY:
74322
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Likely benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not specified Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine | Mar 29, 2016 | Variant identified in a genome or exome case(s) and assessed due to predicted null impact of the variant or pathogenic assertions in the literature or databases. Disclaimer: This variant has not undergone full assessment. The following are preliminary notes: Silent, not in splice consensus - |
not provided Benign:1
Likely benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at